Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Takatoshi Otonari"'
Autor:
Kazumasa Harada, Takumi Imai, Hidenori Arai, Kazuo Sakabe, Yasuo Katayama, Shiro Tanaka, Naoto Yokota, Takao Urabe, Koutaro Yokote, Yasuo Ohashi, Shinichi Oikawa, Takashi Kobayashi, Shizuya Yamashita, Yasufumi Uchida, Masayasu Yamamoto, Hirokazu Nishida, Hideki Ito, Masanari Kuwabara, Jun Sasaki, Ichiro Sakuma, Masaru Hayashi, Yasuyoshi Ouchi, Hiromi Rakugi, Takatoshi Otonari, Tadashi Arai
Publikováno v:
Circulation. 140:992-1003
Background: Evidence regarding the primary prevention of coronary artery disease events by low-density lipoprotein cholesterol (LDL-C) lowering therapy in older individuals, aged ≥75 years, is insufficient. This trial tested whether LDL-C–lowerin
Autor:
Mitsuhiro Tominaga, Junya Kawasaki, Hisatomi Arima, Yuki Morinaga, Comfort Investigators, Masayo Fukuhara, Yuko Ohta, Toshio Ohtsubo, Isao Kato, Toshiyuki Sasaguri, Takuya Tsuchihashi, Takatoshi Otonari, Kiyoshi Matsumura, Koji Fujii, Keiko Uezono
Publikováno v:
Clinical and Experimental Hypertension. 37:192-196
It has been shown that losartan, an angiotensin II receptor blocker (ARB), reduces serum uric acid levels. However, the effects of losartan on serum uric acid levels in the patients treated with a thiazide diuretic have not been fully elucidated. We
Autor:
Shinichi Oikawa, Takeshi Inazawa, Yasushi Nakajima, Takatoshi Otonari, Taro Harada, Fumitaka Okajima, Hitoshi Sugihara, Masanobu Kawakami, Hideki Tamura, Mototsugu Nagao, Kyoko Tanimura-Inagaki
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction α-Glucosidase inhibitors (αGIs) are widely used for the primary treatment of type 2 diabetes. We compared the clinical effects of three αGIs (miglitol, acarbose and voglibose) in patients with obese type 2 diabetes. Materials and
Autor:
Jun, Sasaki, Takatoshi, Otonari, Yasunori, Sawayama, Shiro, Hata, Yoshimi, Oshima, Tetsunori, Saikawa, Sadatoshi, Biro, Suminori, Kono, S, Suzuki
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 19:485-493
Aim This study compared the effect of doubling the dose of pravastatin with that of adding ezetimibe to low-dose pravastatin on the LDL cholesterol (LDL-C) level and on cholesterol absorption and synthesis markers. The tolerability of the 2 regimens
Autor:
Syozou Kobori, Tetsunori Saikawa, Keizou Kajiwara, Masato Ageta, Yoshihiko Ikeda, Tadanobu Kuribayashi, Kyosuke Yamamoto, Suminori Kono, Jun Sasaki, Sadatoshi Biro, Takatoshi Otonari
Publikováno v:
Clinical Therapeutics. 30:1089-1101
Statin therapy has been found to produce substantial reductions in low-density lipoprotein cholesterol (LDL-C) levels, resulting in a reduced risk for cardiovascular events. Recently, research interest has focused on modification of high-density lipo
Autor:
Takatoshi Otonari, Jun Sasaki, Tetsunori Saikawa, Sadatoshi Biro, Yasunori Sawayama, Hachiro Obata, Masato Ageta, Suminori Kono
Publikováno v:
Clinical Pharmacology & Biopharmaceutics. 3
Activation of renin angiotensin system is implicated in insulin resistance. In mega trials, it has been suggested that angiotensin receptor blockers may be beneficial on insulin sensitivity in hypertensive patients. We conducted a multicenter, open-l
Autor:
Mitsuhiro Tominaga, Kiyoshi Matsumura, Takatoshi Otonari, Hisatomi Arima, Yuko Ohta, Yuki Morinaga, Toshiyuki Sasaguri, Toshio Ohtsubo, Comfort Investigators, Isao Kato, Masayo Fukuhara, Takuya Tsuchihashi, Junya Kawasaki, Keiko Uezono, Koji Fujii
Publikováno v:
QJM : monthly journal of the Association of Physicians. 106(10)
Background: It has not been fully elucidated whether antihypertensive medication adherence affects blood pressure (BP) control in hypertension cases. Aim: To investigate the association of adherence to antihypertensive drug regimens and BP control us
Autor:
Jun, Sasaki, Takatoshi, Otonari, Yasufumi, Uchida, Yoshihiko, Ikeda, Sadatoshi, Biro, Suminori, Kono, K, Gondo
Publikováno v:
Journal of atherosclerosis and thrombosis. 20(4)
Aims: While statins have the property of increasing high-density lipoprotein cholesterol (HDL-C) in addition to lowering low-density lipoprotein cholesterol (LDL-C), a potential adverse effect on glucose metabolism has raised a concern over statin th
Autor:
Kiyoshi, Matsumura, Hisatomi, Arima, Mitsuhiro, Tominaga, Toshio, Ohtsubo, Toshiyuki, Sasaguri, Koji, Fujii, Masayo, Fukuhara, Keiko, Uezono, Yuki, Morinaga, Yuko, Ohta, Takatoshi, Otonari, Junya, Kawasaki, Isao, Kato, Takuya, Tsuchihashi, Morioki, Ishibashi
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 76(6)
Background: In order to achieve target blood pressure levels to prevent cardiovascular disease, combination therapy of antihypertensive drugs is often required, although it is thought that requiring a patient to take many different pills would reduce
Autor:
Tetsunori, Saikawa, Jun, Sasaki, Sadayoshi, Biro, Suminori, Kono, Takatoshi, Otonari, Yoshiyuki, Ikeda, S, Kono
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 33(9)
Whether the reno-protective effect of angiotensin receptor blockers is dose dependent is unknown for the Japanese population. We sought to elucidate the dose-dependent reno-protective effects of valsartan in Japanese hypertensive patients with albumi